InfliximabMedication related osteonecrosis of jaw: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1686卷 / 1期

关键词：

D O I：

10.1007/s40278-018-41270-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：207 / 207

相关论文

共 50 条

[31] Zoledronic acidMedication-related osteonecrosis of the jaw: case report
Reactions Weekly, 2021, 1840 (1) : 358 - 358
[32] Zoledronic acidMedication-related osteonecrosis of jaw: case report
Reactions Weekly, 2021, 1867 (1) : 396 - 396
[33] Pamidronic acidMedication-related osteonecrosis of the jaw: case report
Reactions Weekly, 2017, 1681 (1) : 279 - 279
[34] Alendronic-acidMedication-related osteonecrosis of jaw: case report
Reactions Weekly, 2024, 2028 (1) : 29 - 29
[35] Zoledronic-acidMedication-related osteonecrosis of the jaw: case report
Reactions Weekly, 2022, 1913 (1) : 435 - 435
[36] Risedronic-acidBisphosphonate related osteonecrosis of the jaw: case report
Reactions Weekly, 2016, 1586 (1) : 254 - 254
[37] Zoledronic-acidBisphosphonate-related osteonecrosis of the jaw: case report
Reactions Weekly, 2015, 1565 (1) : 258 - 258
[38] Risedronic acidMedication-related osteonecrosis of the jaw: case report
Reactions Weekly, 2020, 1816 (1) : 285 - 285
[39] Alendronic acidBisphosphonate-related osteonecrosis of the jaw: case report
Reactions Weekly, 2016, 1611 (1) : 17 - 17
[40] DenosumabAntiresorptive agent-related osteonecrosis of the jaw: case report
Reactions Weekly, 2022, 1901 (1) : 198 - 198

← 1 2 3 4 5 →